RESEARCH AND MARKETS: Ramucirumab (Non-Small Cell Lung Cancer … – 4-traders (press release)

by lowes1 on October 8, 2013

RESEARCH AND MARKETS: Ramucirumab (Non-Small Cell Lung Cancer
4-traders (press release)
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: